Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus
dc.citation.issue | 7 | |
dc.citation.volume | v. 217 | |
dc.contributor.author | Negri, Clara Ezequiel [UNIFESP] | |
dc.contributor.author | Johnson, Adam | |
dc.contributor.author | McEntee, Laura | |
dc.contributor.author | Box, Helen | |
dc.contributor.author | Whalley, Sarah | |
dc.contributor.author | Schwartz, Julie A. | |
dc.contributor.author | Ramos-Martin, V. | |
dc.contributor.author | Livermore, Joanne | |
dc.contributor.author | Kolamunnage-Dona, Ruwanthi | |
dc.contributor.author | Colombo, Arnaldo Lopes [UNIFESP] | |
dc.contributor.author | Hope, William W. | |
dc.coverage | Cary | |
dc.date.accessioned | 2020-07-20T16:31:11Z | |
dc.date.available | 2020-07-20T16:31:11Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Background. Aspergillus flavus is one of the most common agents of invasive aspergillosis and is associated with high mortality. The orotomides are a new class of antifungal agents with a novel mechanism of action. An understanding of the pharmacodynamics (PD) of the lead compound F901318 is required to plan safe and effective regimens for clinical use. Methods. The pharmacokinetics (PK) and PD of F901318 were evaluated by developing new in vitro and in vivo models of invasive fungal sinusitis. Galactomannan was used as a pharmacodynamic endpoint in all models. Mathematical PK-PD models were used to describe dose-exposure-response relationships. Results. F901318 minimum inhibitory concentrations (MICs) ranged from 0.015 to 0.06 mg/L. F901318 induced a concentration-dependent decline in galactomannan. In the in vitro model, a minimum concentration: MIC of 10 resulted in suppression of galactomannan | en |
dc.description.abstract | however, values of approximately 10 and 9-19 when assessed by survival of mice or the decline in galactomannan, respectively, were equivalent or exceeded the effect induced by posaconazole. There was histological clearance of lung tissue that was consistent with the effects of F901318 on galactomannan. Conclusions. F901318 is a potential new agent for the treatment of invasive infections caused by A flavus with PDs that are comparable with other first-line triazole agents. | en |
dc.description.affiliation | Univ Fed Sao Paulo, Escola Paulista Med, Disciplina Infectol, Lab Especial Micol, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Liverpool, Antimicrobial Pharmacodynam & Therapeut, Liverpool, Merseyside, England | |
dc.description.affiliation | Charles River Labs, Davis, CA USA | |
dc.description.affiliation | Univ Liverpool, Inst Translat Med, Dept Biostat, Liverpool, Merseyside, England | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Escola Paulista Med, Disciplina Infectol, Lab Especial Micol, Sao Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | F2G Ltd. | |
dc.description.sponsorship | National Institute of Health Research Clinician Scientist Award | |
dc.description.sponsorship | CAPES PROEX | |
dc.description.sponsorship | CAPES-PDSE | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil | |
dc.description.sponsorshipID | NIH-RCS: CS/08/08 | |
dc.description.sponsorshipID | CAPES: 99999.008426/2014-07 | |
dc.description.sponsorshipID | CNPq: 307510/2015-8 | |
dc.format.extent | 1118-1127 | |
dc.identifier | http://dx.doi.org/10.1093/infdis/jix479 | |
dc.identifier.citation | Journal Of Infectious Diseases. Cary, v. 217, n. 7, p. 1118-1127, 2018. | |
dc.identifier.doi | 10.1093/infdis/jix479 | |
dc.identifier.file | WOS000427845800014.pdf | |
dc.identifier.issn | 0022-1899 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/55775 | |
dc.identifier.wos | WOS:000427845800014 | |
dc.language.iso | eng | |
dc.publisher | Oxford Univ Press Inc | |
dc.relation.ispartof | Journal Of Infectious Diseases | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Aspergillus flavus | en |
dc.subject | in vivo | en |
dc.subject | orotomides | en |
dc.subject | pharmacodynamics | en |
dc.subject | pharmacokinetics | en |
dc.title | Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus | en |
dc.type | info:eu-repo/semantics/article |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- WOS000427845800014.pdf
- Tamanho:
- 4.74 MB
- Formato:
- Adobe Portable Document Format
- Descrição: